Market Overview
Joint replacement surgery involves replacing diseased or damaged joint surfaces with prosthetic devices made of metal, plastic, or ceramic components. The market covers primary and revision procedures across major joint categories, with total knee and hip replacements representing the largest segments. Clinical demand is tracked through national joint registries that monitor implant performance and procedural outcomes.
- •Market valued at approximately $20.7 billion in 2025, with projections ranging to $31-32 billion by 2030 depending on scope and methodology
- •Total knee replacement segment alone accounted for roughly $10.2 billion in 2025 with a growth rate near 5.3% annually
- •Procedures are documented in national registries including the American Joint Replacement Registry which publishes annual clinical outcome data
Growth Drivers
The primary force behind market expansion is the aging global population, as osteoarthritis and degenerative joint disease prevalence increases significantly with age. Rising obesity rates contribute to earlier onset and accelerated progression of joint deterioration requiring surgical intervention. Additionally, improvements in implant longevity, minimally invasive surgical techniques, and expanded healthcare access in emerging economies are broadening the eligible patient pool.
- •Osteoarthritis affects millions worldwide and represents the leading indication for joint replacement procedures
- •Baby boomer demographics and increasing life expectancy are expanding the addressable patient population
- •Advancements in biocompatible materials and personalized implant design are supporting higher procedure volumes
Segmentation and Regional Analysis
The market is segmented by product type including knee implants, hip implants, and other joints such as shoulder and ankle replacements. Knee replacements constitute the largest category, followed by hip replacements, while smaller joint segments are growing at above-average rates. Geographically, North America holds the largest share driven by high procedure volumes and advanced healthcare infrastructure, while Asia-Pacific represents the fastest-growing region due to rising medical tourism and expanding orthopedic services.
- •Knee replacement leads the market with approximately $10.2 billion in 2025 value, while hip and other joint segments fill the remainder
- •North America dominates regional share supported by established reimbursement systems and high surgeon adoption of advanced technologies
- •Asia-Pacific growth is accelerating as healthcare systems expand and surgical techniques become more widely available
Trends and Outlook
What are the recent trends and outlook?
Emerging trends include adoption of sensor-enabled smart implants that transmit postoperative data, increased use of robotic-assisted surgical systems, and development of 3D-printed patient-specific implants. Value-based care models are shifting reimbursement toward outcomes and implant longevity rather than volume of procedures performed. The market is expected to maintain steady growth as these innovations reduce complication rates and expand candidacy to younger, more active patients.
- •Smart implants with embedded sensors are being introduced to monitor joint function and predict potential failures
- •Robotic surgical platforms and navigation systems are improving implant positioning accuracy and consistency
- •3D printing technology enables customized implants matched to individual patient anatomy, particularly benefiting complex revision cases
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.